Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to ...
Alpha Cognition (ACOG) announced the strategic appointments of Jen Pesa, Vice President of Commercial; Jack Kelly, Head of Market Access; ...
Anavex's financial health is stable with cash runway into 2028, but rising expenses are expected. Click here to find out why ...
VANCOUVER, British Columbia & DALLAS, January 08, 2025--Alpha Cognition, Inc. (Nasdaq: ACOG) ("ACI" or the "Company"), a biopharmaceutical company developing novel therapeutics for debilitating ...
5d
Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...
Collaboration and Distribution Agreement (the “Agreement”) with Alpha Cognition Inc. (“Alpha”) of the improved new drug ZUNVEYL（benzgalantamine delayed-release tablets）(“ZUNVEY” or the “Product”) for ...
The agreement with China Medical System Holdings Limited is for the development, manufacturing, and commercialization of ...
Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.
Researchers have assessed the human perception of the size and weight of body parts, specifically the hand, comparing it to the perception of objects ...
Equiti, a leading global fintech, announced that it has received in-principle approval from the Securities and Commodities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback